| NCT ID | NCT05277129 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Oslo |
| Condition | Stroke, Acute |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2021-06-24 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2021-06-24 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Some patients develop cognitive decline after a stroke, but we don't always understand the mechanisms. It has been proposed that a proportion of the patients develop an autoimmune immune response, and that this could potentially explain the cognitive decline in some of the patients. The current study aims to investigate this hypothesis in a subgroup of patients with stroke.
Eligibility Criteria
Inclusion Criteria: * Stroke \< 72 h * Age \> 18 years Exclusion Criteria: * Brain hemorrhage verified by CT or MRI scan * Previous or present immunological disease or other serious comorbidity * Ongoing immune respons after infection or vaccination \< 1 month * Cognitive without ability to understand and/or give an informed consent to participate in the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05277129 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke, Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05277129 currently recruiting?
Yes, NCT05277129 is actively recruiting participants. Contact the research team at postmottak@medisin.uio.no for enrollment information.
Where is the NCT05277129 trial being conducted?
This trial is being conducted at Lørenskog, Norway.
Who is sponsoring the NCT05277129 clinical trial?
NCT05277129 is sponsored by University of Oslo. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.